Article Details

Asthma-focused Aiolos Bio takes aim at Tezspire, launches with $245M raise

Retrieved on: 2023-10-26 16:54:12

Tags for this article:

Click the tags to see associated articles and topics

Asthma-focused Aiolos Bio takes aim at Tezspire, launches with $245M raise. View article details on hiswai:

Excerpt

The biotech startup is aiming to best Tezspire, AstraZeneca's add-on asthma maintenance drug. The Series A raise was co-led by Atlas Venture, Bain ...

Article found on: www.mmm-online.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up